ReviewInternational journal of general medicine2026
Cellular Biological Basis and Novel Breakthroughs in the Pathogenesis of Myopia - A Narrative Review.
Review in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopia has evolved into a severe global public health concern, exhibiting an epidemiological trend of earlier onset and higher refractive errors particularly among adolescents. Complications induced by high myopia, such as retinal detachment and macular degeneration, pose grave threats to visual health. This paper is a narrative review. It summarizes advances in the cell biology of myopia, elucidates the mechanisms underlying myopia mediated by multiple intraocular cell types, interprets several interactive regulatory pathways, and reviews biomarkers, targeted interventions and detection technologies. Different from previous reviews, this paper links retinal light signaling, intraocular cross‑tissue communication and scleral remodeling, with a focus on corneal biomechanics and the crosstalk between immunity and aging. It establishes an integrated analytical framework of "retinal phototransduction - trans-tissue cellular communication - scleral matrix remodeling", from which three core mechanistic conclusions are drawn: 1) Myopia is a sterile, chronic low-grade inflammation driven by coordinated dysfunction of multiple ocular tissue cells; cellular senescence and localized inflammation form a positive feedback loop that continuously fuels excessive axial elongation. 2) Retinal glial cells and retinal pigment epithelium serve as relays for visual growth signals. Abnormal defocus disrupts their secretion of cytokines, breaking the homeostasis of scleral collagen synthesis and degradation. 3) The hypoxic microenvironment of the choroid can amplify scleral remodeling and exacerbate myopia progression. Integrating the multilayered signaling regulatory network formed by cells of the cornea, retina and sclera helps clarify the complete pathological logic underlying multicellular synergistic pathogenesis of myopia. It provides mechanistic evidence for the clinical development of an early myopia warning system, tissue-specific targeted pharmaceuticals and stratified individualized prevention and control regimens, and facilitates the shift of myopia intervention from conventional empirical management to a novel precision diagnosis and treatment paradigm grounded in cellular and molecular characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.